- Report
- April 2025
- 50 Pages
Global
From €2425EUR$2,650USD£2,107GBP
- Report
- October 2024
- 192 Pages
Global
From €3244EUR$3,545USD£2,819GBP
€3605EUR$3,939USD£3,132GBP
- Report
- October 2024
- 187 Pages
Global
From €3244EUR$3,545USD£2,819GBP
€3605EUR$3,939USD£3,132GBP
- Report
- December 2024
- 100 Pages
Global
From €5445EUR$5,950USD£4,731GBP
- Report
- April 2025
- 174 Pages
Global
From €4987EUR$5,450USD£4,333GBP
- Report
- March 2025
- 175 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- February 2025
- 200 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- May 2024
- 131 Pages
Global
From €5947EUR$6,499USD£5,167GBP
- Report
- May 2024
- 129 Pages
Global
From €5947EUR$6,499USD£5,167GBP
- Report
- May 2024
- 132 Pages
Global
From €5947EUR$6,499USD£5,167GBP
- Report
- May 2024
- 139 Pages
Global
From €5947EUR$6,499USD£5,167GBP
- Report
- May 2024
- 130 Pages
Global
From €5947EUR$6,499USD£5,167GBP
- Clinical Trials
- August 2024
- 80 Pages
Global
From €1830EUR$2,000USD£1,590GBP
- Report
- February 2021
- 420 Pages
United States
From €1977EUR$2,160USD£1,717GBP
€2196EUR$2,400USD£1,908GBP
- Report
- August 2023
- 133 Pages
Global
From €6863EUR$7,500USD£5,963GBP
- Report
- July 2023
- 129 Pages
Global
From €6863EUR$7,500USD£5,963GBP
- Report
- May 2023
- 160 Pages
Global
From €4529EUR$4,949USD£3,935GBP
- Report
- August 2024
- 80 Pages
Japan
From €3203EUR$3,500USD£2,783GBP
- Report
- February 2024
- 94 Pages
Global
From €3500EUR$4,097USD£3,147GBP
- Report
- February 2024
- 90 Pages
Global
From €3500EUR$4,097USD£3,147GBP

Sertraline is a type of antidepressant medication used to treat mental disorders such as depression, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, and social anxiety disorder. It is a selective serotonin reuptake inhibitor (SSRI) and is one of the most commonly prescribed medications for mental health conditions. It works by increasing the amount of serotonin, a neurotransmitter, in the brain.
The sertraline market is highly competitive, with many pharmaceutical companies offering generic and branded versions of the drug. The market is expected to grow in the coming years due to the increasing prevalence of mental health disorders and the growing awareness of the importance of mental health.
Some of the companies in the sertraline market include Pfizer, GlaxoSmithKline, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more